GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · IEX Real-Time Price · USD
0.284
-0.012 (-3.98%)
At close: Jul 19, 2024, 4:00 PM
0.285
+0.001 (0.18%)
Pre-market: Jul 22, 2024, 7:33 AM EDT
GlycoMimetics Stock Forecast
GLYC's stock price has decreased by -82.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for GlycoMimetics stock has a target of 12, which predicts an increase of 4,119.41% from the current stock price of 0.28.
Analyst Consensus: Buy
* Price targets were last updated on Dec 22, 2023.
Analyst Ratings
The average analyst rating for GlycoMimetics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +2,712.94% | Mar 27, 2024 |
| Capital One | Capital One | Buy Initiates $12 | Buy | Initiates | $12 | +4,119.41% | Dec 22, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +2,712.94% | Aug 3, 2023 |
Financial Forecast
Revenue This Year
n/a
from 10.00K
Revenue Next Year
2.73M
EPS This Year
-0.63
from -0.58
EPS Next Year
-0.46
from -0.63
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 11.2M | 4.0M | 11.6M | 62.3M |
| Avg | n/a | 2.7M | 969,000 | 6.5M | 32.6M |
| Low | n/a | n/a | n/a | n/a | 14.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 46.4% | 1,099.6% | 855.3% |
| Avg | - | - | -64.5% | 572.7% | 399.7% |
| Low | - | - | - | - | 125.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.54 | -0.08 | -0.08 | -0.71 | -0.15 |
| Avg | -0.63 | -0.46 | -0.53 | -0.69 | -0.14 |
| Low | -0.74 | -0.88 | -1.42 | -0.67 | -0.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.